Korean startup byL, which operates senior healthcare services, has secured an investment of approximately USD 7.3 million(KRW 10 billion) from KB Investment. In this round, byL’s existing major shareholder Alchera sold approximately USD 3.6 million(KRW 5 billion) worth of convertible bonds to KB Investment. Through this transaction, KB Investment became the largest shareholder of byL.
Building on the newly secured capital, Alchera and byL plan to expand home-based care and day-care centers while accelerating their AI data-driven healthcare business. The two companies aim to strengthen synergies between AI technology and financial services in the rapidly growing senior care market.
With KB Investment’s funding, byL intends to expand its home-care beneficiaries tenfold by 2029, gradually scale its day-care centers across Seoul, and test non-reimbursable services to validate sustainable revenue models and drive stable growth.
Furthermore, byL will leverage Alchera’s Vision AI technology to collect senior health and behavioral data from data centers, integrating it with its care network. This will enable predictive insights into elderly health deterioration while generating insurance and healthcare-linked datasets. Such capabilities are expected to foster private insurance and B2B business expansion, positioning the company with a unique competitive edge in Korea’s senior data market.
This transaction marks the first investment of KB Investment’s newly established Venture Division 5, launched in July under a newly recruited leadership team. Beyond minority equity investments, KB Investment aims to pursue structured investments in high-growth sectors while creating strategic synergies that significantly enhance enterprise value.
MORE FROM THE POST
- TRIOAR Raises $16M in Series B to Advance Antibody-Based Drug Development Platforms
- Kickstart Ventures Backs Lydia.ai to Advance AI Health Scoring Across Asia
- PinTherapeutics Targets Clinical Trials and Growth with $15.4M Series C Investment
- ALDAVER Raises $8.4M to Expand Biopolymer-Based Artificial Organ Simulators
- Endo Health Secures Funding From General Catalyst to Transform Digital Healthcare
Share
Most Read
- 1
- 2
- 3
- 4
- 5
Leave a Reply